$38.36 +0.10 (0.26%)

Trimas Corporation (TRS)

Trimas Corporation (TRS) is a diversified industrial company that designs, manufactures, and markets components, assemblies, and products primarily for the agriculture, transportation, and industrial markets. The company operates through various business segments, offering solutions that include precision-machined parts, vehicle accessories, and structural components. Trimas focuses on providing innovative, high-quality products and services to enhance the efficiency and performance of its customers' applications.

Dividend Yield 0.42%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
August 12, 2025$0.042025-08-052025-08-05
May 13, 2025$0.042025-05-062025-05-06
March 7, 2025$0.042025-02-282025-02-28
November 12, 2024$0.042024-11-052024-11-05
August 13, 2024$0.042024-08-062024-08-06

Dividends Summary

Company News

Aircraft Screw Market is Forecasted to Reach US$ 1.4 Billion in 2032, Says Stratview Research
GlobeNewswire Inc. • N/A • March 20, 2025

The global aircraft screw market is projected to grow at a CAGR of 3.9% from 2024 to 2032, reaching a size of $1.4 billion by 2032. The growth is driven by increasing aircraft production, demand for lightweight materials, and advancements in screw design.

Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion - Zacks Investment Research
Zacks Investment Research • Zacks.Com • July 22, 2024

The article discusses 5 top small-cap stocks that are Zacks Rank #1 (Strong Buy) or #2 (Buy) stocks, including Soundhound AI, Afya, Castle Biosciences, TriMas, and Immersion. The article provides an overview of each company's business, market cap, stock performance, and earnings growth outlook.

Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Benzinga • Benzinga Insights • May 22, 2023

Upgrades For Avidity Biosciences Inc (NASDAQ:RNA), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. In the first quarter, Avidity Biosciences showed an EPS of $0.74, compared to $0.71 from the year-ago quarter. The current stock performance of Avidity Biosciences shows a 52-week-high of $25.74 and a 52-week-low of $9.88. ...

TriMas Corporation (TRS) Q3 2021 Earnings Call Transcript
The Motley Fool [email protected] (Motley Fool Transcribers) • October 29, 2021

TRS earnings call for the period ending September 30, 2021.